Letters
Volume 27—2021
Volume 27, Number 10—October 2021
Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016 [PDF - 633 KB - 1 page]
| EID | Bharat A, Murphy CP, Mulvey MR, Hussain S, Carson CA, Reid-Smith RJ. Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016. Emerg Infect Dis. 2021;27(10):2746. https://doi.org/10.3201/eid2710.211339 |
|---|---|
| AMA | Bharat A, Murphy CP, Mulvey MR, et al. Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016. Emerging Infectious Diseases. 2021;27(10):2746. doi:10.3201/eid2710.211339. |
| APA | Bharat, A., Murphy, C. P., Mulvey, M. R., Hussain, S., Carson, C. A., & Reid-Smith, R. J. (2021). Antimicrobial-Resistant Nontyphoidal Salmonella Infections, United States, 2004–2016. Emerging Infectious Diseases, 27(10), 2746. https://doi.org/10.3201/eid2710.211339. |
Volume 27, Number 9—September 2021
Fecal Excretion of Mycobacterium leprae, Burkina Faso [PDF - 633 KB - 2 pages]
| EID | Singh A, Yadav R, Pawar H, Chauhan D. Fecal Excretion of Mycobacterium leprae, Burkina Faso. Emerg Infect Dis. 2021;27(9):2507-2508. https://doi.org/10.3201/eid2709.211262 |
|---|---|
| AMA | Singh A, Yadav R, Pawar H, et al. Fecal Excretion of Mycobacterium leprae, Burkina Faso. Emerging Infectious Diseases. 2021;27(9):2507-2508. doi:10.3201/eid2709.211262. |
| APA | Singh, A., Yadav, R., Pawar, H., & Chauhan, D. (2021). Fecal Excretion of Mycobacterium leprae, Burkina Faso. Emerging Infectious Diseases, 27(9), 2507-2508. https://doi.org/10.3201/eid2709.211262. |
SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021 [PDF - 630 KB - 1 page]
| EID | Marr LC. SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021. Emerg Infect Dis. 2021;27(9):2507. https://doi.org/10.3201/eid2709.211177 |
|---|---|
| AMA | Marr LC. SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021. Emerging Infectious Diseases. 2021;27(9):2507. doi:10.3201/eid2709.211177. |
| APA | Marr, L. C. (2021). SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021. Emerging Infectious Diseases, 27(9), 2507. https://doi.org/10.3201/eid2709.211177. |
Volume 27, Number 8—August 2021
Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children [PDF - 703 KB - 2 pages]
| EID | Levy C, Ouldali N, Varon E, Béchet S, Bonacorsi S, Cohen R. Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children. Emerg Infect Dis. 2021;27(8):2240-2241. https://doi.org/10.3201/eid2708.210037 |
|---|---|
| AMA | Levy C, Ouldali N, Varon E, et al. Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children. Emerging Infectious Diseases. 2021;27(8):2240-2241. doi:10.3201/eid2708.210037. |
| APA | Levy, C., Ouldali, N., Varon, E., Béchet, S., Bonacorsi, S., & Cohen, R. (2021). Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children. Emerging Infectious Diseases, 27(8), 2240-2241. https://doi.org/10.3201/eid2708.210037. |
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States [PDF - 863 KB - 2 pages]
| EID | DeFlorio-Barker S, Shrestha A, Dorevitch S. Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States. Emerg Infect Dis. 2021;27(8):2241-2242. https://doi.org/10.3201/eid2708.210242 |
|---|---|
| AMA | DeFlorio-Barker S, Shrestha A, Dorevitch S. Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States. Emerging Infectious Diseases. 2021;27(8):2241-2242. doi:10.3201/eid2708.210242. |
| APA | DeFlorio-Barker, S., Shrestha, A., & Dorevitch, S. (2021). Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States. Emerging Infectious Diseases, 27(8), 2241-2242. https://doi.org/10.3201/eid2708.210242. |
Volume 27, Number 6—June 2021
Postvaccination COVID-19 among Healthcare Workers, Israel [PDF - 572 KB - 1 page]
| EID | Yousaf Z, Mushtaq K. Postvaccination COVID-19 among Healthcare Workers, Israel. Emerg Infect Dis. 2021;27(6):1761. https://doi.org/10.3201/eid2706.210410 |
|---|---|
| AMA | Yousaf Z, Mushtaq K. Postvaccination COVID-19 among Healthcare Workers, Israel. Emerging Infectious Diseases. 2021;27(6):1761. doi:10.3201/eid2706.210410. |
| APA | Yousaf, Z., & Mushtaq, K. (2021). Postvaccination COVID-19 among Healthcare Workers, Israel. Emerging Infectious Diseases, 27(6), 1761. https://doi.org/10.3201/eid2706.210410. |
Volume 27, Number 1—January 2021
Large-Scale Isolation Facilities and Potential for Secondary Infectious Disease Outbreak [PDF - 527 KB - 2 pages]
| EID | Lim SD, Tey H. Large-Scale Isolation Facilities and Potential for Secondary Infectious Disease Outbreak. Emerg Infect Dis. 2021;27(1):334-335. https://doi.org/10.3201/eid2701.203127 |
|---|---|
| AMA | Lim SD, Tey H. Large-Scale Isolation Facilities and Potential for Secondary Infectious Disease Outbreak. Emerging Infectious Diseases. 2021;27(1):334-335. doi:10.3201/eid2701.203127. |
| APA | Lim, S. D., & Tey, H. (2021). Large-Scale Isolation Facilities and Potential for Secondary Infectious Disease Outbreak. Emerging Infectious Diseases, 27(1), 334-335. https://doi.org/10.3201/eid2701.203127. |
Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan [PDF - 194 KB - 1 page]
| EID | Yan G, Ang A, Tham S, Ng A, Chew K. Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan. Emerg Infect Dis. 2021;27(1):335. https://doi.org/10.3201/eid2701.203312 |
|---|---|
| AMA | Yan G, Ang A, Tham S, et al. Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan. Emerging Infectious Diseases. 2021;27(1):335. doi:10.3201/eid2701.203312. |
| APA | Yan, G., Ang, A., Tham, S., Ng, A., & Chew, K. (2021). Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan. Emerging Infectious Diseases, 27(1), 335. https://doi.org/10.3201/eid2701.203312. |
Page created: September 29, 2020
Page updated: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
